ABVC BioPharma Inc. (ABVC)
NASDAQ: ABVC
· Real-Time Price · USD
2.90
0.05 (1.75%)
At close: Aug 20, 2025, 10:06 AM
ABVC BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 1.97K | 389.28K | 117.14K | 1.21K | 2.17K | 15.88K | 6.11K | 128.27K | 588.99K | 42.27K | 312.86K | 25.66K | -37.79K | 99K | 31.44K | 263.15K |
Cost of Revenue | n/a | 113.95K | 2.05K | 296.00 | 190.00 | 277.00 | 139.21K | 29.61K | 72.98K | 60.24K | 265.41K | 10.74K | 8.37K | 1.9K | 2.8K | 393.00 | 646.00 | 1.25K |
Gross Profit | n/a | -113.95K | 1.97K | 388.98K | 116.95K | 928.00 | -137K | -13.73K | -66.87K | 68.04K | 323.58K | 31.53K | 304.49K | 23.76K | -40.59K | 98.61K | 30.8K | 261.9K |
Operating Income | -2.29M | -693K | -334K | 49.95K | -977K | -2.84M | -1.96M | -2.15M | -2.19M | -1.91M | -3.13M | -3.72M | -2.05M | -6.22M | -6.45M | -1.97M | -2.04M | -1.25M |
Interest Income | 19.14K | 19.07K | 11.91K | 44.26K | 27.14K | 4.05K | 37.48K | 40.25K | 55.04K | 52.71K | 60.46K | 48.16K | 39.02K | 40.17K | n/a | 9.33K | 10.72K | 52.53K |
Pretax Income | -2.31M | -944K | 128.94K | -133.92K | -1.38M | -2.93M | -3.15M | -3.37M | -2.23M | -1.9M | -3.54M | -3.77M | -2.03M | -6.17M | -5.89M | -1.96M | -2.11M | -1.25M |
Net Income | -2.33M | -842K | 229.3K | -186.56K | -1.01M | -2.83M | -3.11M | -3.32M | -2.26M | -1.82M | -4.86M | -3.7M | -1.86M | -6M | -7.93M | -1.81M | -1.97M | -1.13M |
Selling & General & Admin | 690.09K | 664.14K | 304.14K | 301.21K | 1.05M | 2.77M | 1.75M | 2M | 1.61M | 1.64M | 1.96M | 3.44M | 1.82M | 5.88M | 6.15M | 1.81M | 1.71M | 1.39M |
Research & Development | 33.28K | 28.86K | 31.98K | 37.83K | 40.4K | 69.07K | 72.19K | 141.31K | 514.44K | 334.98K | 1.5M | 305.48K | 532.78K | 359.4K | 260.19K | 263.42K | 358.88K | 121.31K |
Other Expenses | 1.57M | n/a | n/a | n/a | 599.00 | n/a | -185 | -310 | n/a | n/a | n/a | 22.09K | -17.66K | 14.71K | n/a | 3.42K | n/a | 6.54K |
Operating Expenses | 2.29M | 693K | 336.12K | 339.03K | 1.09M | 2.84M | 1.82M | 2.14M | 2.13M | 1.97M | 3.46M | 3.75M | 2.35M | 6.24M | 6.41M | 2.07M | 2.07M | 1.51M |
Interest Expense | -129.41K | 222.97K | -338.35K | 219.53K | 260.03K | 684.68K | 1.1M | 1.22M | 114.75K | 56.66K | 134.46K | 126.54K | 14.76K | 18.21K | n/a | 38.68K | 82.67K | 130.23K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -7.58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 693K | 336.12K | 339.33K | 1.09M | 3.45M | 1.96M | 2.17M | 2.2M | 2.03M | 3.72M | 3.76M | 2.36M | 6.24M | 6.41M | 2.07M | 2.07M | 1.52M |
Income Tax Expense | 23.63K | n/a | n/a | 355.00 | -111K | -3.93M | 175.31K | -999 | 81.69K | n/a | 962.87K | 4.22K | -82.45K | -86.87K | 1.01M | -75.67K | -59.56K | -51.02K |
Shares Outstanding (Basic) | 17.39M | 14.97M | 13.2M | 12.41M | 11.32M | 9.74M | 4.2M | 4.05M | 3.31M | 3.31M | 3.31M | 3.26M | 3.13M | 2.97M | 2.51M | 2.58M | 2.44M | 2.44M |
Shares Outstanding (Diluted) | 17.39M | 14.97M | 13.2M | 12.41M | 11.32M | 9.74M | 6.68M | 4.05M | 3.31M | 3.31M | 3.31M | 3.26M | 3.13M | 2.97M | 2.51M | 2.69M | 2.44M | 2.44M |
EPS (Basic) | -0.13 | -0.06 | 0.02 | -0.01 | -0.09 | -0.29 | -0.06 | -0.82 | -0.68 | -0.55 | -1.47 | -1.14 | -0.59 | -2 | -3.16 | -0.7 | -0.81 | -0.46 |
EPS (Diluted) | -0.13 | -0.06 | 0.02 | -0.01 | -0.09 | -0.29 | -0.06 | -0.82 | -0.68 | -0.55 | -1.47 | -1.14 | -0.59 | -2 | -3.16 | -0.67 | -0.8 | -0.46 |
EBITDA | -2.29M | -607K | 308.26K | 92.63K | -1.11M | -2.64M | -2.04M | -2.14M | -2.11M | -1.83M | -3.4M | -3.64M | -2.01M | -6.15M | -5.91M | -1.92M | -2.03M | -1.11M |
EBIT | n/a | -721K | 128.94K | 85.62K | -1.12M | -2.75M | -2.05M | -2.15M | -2.12M | -1.84M | -3.4M | -3.65M | -2.02M | -6.16M | -5.91M | -1.92M | -2.03M | -1.12M |
Depreciation & Amortization | n/a | 113.95K | 179.32K | 7.01K | 13.3K | 102.55K | 7.58K | 7.46K | 7K | 6.49K | 6.43K | 6.46K | 5.49K | 5.41K | 3.27K | 2.86K | 2.94K | 2.93K |